Stelios Papadopoulos serves as Executive at SGX PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Stelios Papadopoulos has executed 157 insider transactions totaling $32.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 19, 2017 involved selling 127,790 shares valued at $3.5M.
Stelios Papadopoulos currently holds 1,189,228 shares of SGX PHARMACEUTICALS, INC. (SGXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stelios Papadopoulos has been a net seller of SGXP stock. They have purchased $8.8M and sold $23.7M worth of shares.
Stelios Papadopoulos's most recent insider trade was on Sep 19, 2017, when they sold 127,790 shares at $27.63 per share.
Get notified when new Form 4 filings are submitted
| $27.76 |
| Discretionary |
| Jul 25, 2017 | RGLS | $910.0K | Purchase | 1,000,000 | $0.91 | Discretionary |
| Jun 7, 2017 | BIIB | $0 | Award | 1,740 | $N/A | Discretionary |
| May 25, 2017 | EXEL | $0 | Award | 5,843 | $N/A | Discretionary |
| May 25, 2017 | EXEL | $0 | Award | 5,843 | $N/A | Discretionary |
| Mar 22, 2017 | RGLS | $369.0K | Purchase | 300,000 | $1.23 | Discretionary |
| Mar 21, 2017 | RGLS | $240.0K | Purchase | 200,000 | $1.20 | Discretionary |
| Mar 20, 2017 | EXEL | $216.6K | Sale | 10,000 | $21.66 | Discretionary |
| Mar 20, 2017 | EXEL | $105.3K | Option Exercise | 10,000 | $10.53 | Discretionary |
| Jun 8, 2016 | BIIB | $0 | Award | 1,590 | $N/A | Discretionary |
| Jan 4, 2016 | EXEL | $0 | Award | 15,071 | $N/A | Discretionary |
| Aug 7, 2015 | RGLS | $41.7K | Option Exercise | 15,677 | $2.66 | Discretionary |
| Aug 7, 2015 | RGLS | $6.7K | Option Exercise | 17,500 | $0.38 | Discretionary |
| Aug 7, 2015 | RGLS | $30.4K | Option Exercise | 17,500 | $1.74 | Discretionary |
| Jul 27, 2015 | BIIB | $1.5M | Purchase | 5,000 | $304.98 | Discretionary |
| Jul 27, 2015 | BIIB | $1.5M | Purchase | 5,000 | $304.78 | Discretionary |
| Jun 10, 2015 | BIIB | $0 | Award | 1,040 | $N/A | Discretionary |
| Dec 12, 2014 | RGLS | $57.0K | Option Exercise | 150,000 | $0.38 | Discretionary |
| Oct 14, 2014 | EXEL | $0 | Award | 69,444 | $N/A | Discretionary |
| Jun 12, 2014 | BIIB | $0 | Award | 870 | $N/A | Discretionary |
| Jun 12, 2014 | BIIB | $0 | Award | 435 | $N/A | Discretionary |
| Jun 12, 2013 | BIIB | $0 | Award | 1,305 | $N/A | Discretionary |
| Jun 11, 2013 | BIIB | $443.6K | Sale | 2,020 | $219.62 | Discretionary |
| Mar 11, 2013 | BIIB | $5.3M | Sale | 31,034 | $172.08 | Discretionary |
| Mar 11, 2013 | BIIB | $337.3K | Option Exercise | 5,700 | $59.17 | Discretionary |
| Mar 11, 2013 | BIIB | $685.0K | Sale | 3,966 | $172.72 | Discretionary |
| Mar 11, 2013 | BIIB | $983.0K | Sale | 5,700 | $172.45 | Discretionary |
| Mar 11, 2013 | BIIB | $2.1M | Option Exercise | 35,000 | $59.17 | Discretionary |
| Mar 11, 2013 | BIIB | $1.0M | Sale | 5,975 | $172.67 | Discretionary |